FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 44 filers reported holding FINCH THERAPEUTICS GROUP INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $322,000 | -45.4% | 192,794 | -7.2% | 0.05% | -45.9% |
| Q2 2022 | $590,000 | -39.9% | 207,729 | +6.4% | 0.10% | -22.8% |
| Q1 2022 | $982,000 | -49.5% | 195,229 | 0.0% | 0.13% | -49.2% |
| Q4 2021 | $1,946,000 | -35.5% | 195,229 | -15.8% | 0.25% | -38.3% |
| Q3 2021 | $3,016,000 | -32.8% | 231,991 | -27.3% | 0.40% | -21.1% |
| Q2 2021 | $4,490,000 | -39.9% | 319,122 | -32.0% | 0.51% | -55.2% |
| Q1 2021 | $7,471,000 | – | 469,584 | – | 1.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avenir Management Company, LLC | 55,445 | $472,946 | 1.27% |